Questions: Ischemia and Reperfusion Injury Pathophysiology

Question 1

A patient arrives in the emergency department 25 minutes after the onset of a myocardial infarction. The blocked coronary artery is successfully reopened. A medical student says 'restoring blood flow stops the injury — the outcome depends only on how much ischemia already occurred.' What is the most accurate correction?

• A. The student is correct; reperfusion itself causes no further damage once flow is restored
• B. Reperfusion causes additional injury through reactive oxygen species bursts, calcium overload, and inflammatory activation — potentially exceeding ischemic damage in brief ischemia cases
• C. Reperfusion is harmful only if ischemia lasted longer than 60 minutes
• D. The main reperfusion risk is re-occlusion of the artery, not a biochemical injury response

Answer: (B)

Reperfusion paradoxically triggers a second wave of injury. Mitochondria damaged by ischemia and calcium-loaded produce a burst of reactive oxygen species when oxygen returns. pH normalization — which was protective during ischemia because low pH inhibits the mitochondrial permeability transition pore (mPTP) — now causes the mPTP to open, collapsing mitochondrial membrane potential and triggering apoptosis. Resident macrophages activate, recruiting neutrophils that amplify oxidant injury. In cases of brief ischemia, this reperfusion injury can actually exceed the ischemic damage that occurred before flow was restored.

Question 2

During ischemia, intracellular pH falls due to anaerobic glycolysis. Why does this low pH, counterintuitively, protect the cell during ischemia — and why does pH normalization at reperfusion cause harm?

• A. Low pH stabilizes mitochondrial membranes by protonating cardiolipin; pH normalization dissolves this protection
• B. Low pH inhibits the mitochondrial permeability transition pore (mPTP); pH normalization at reperfusion opens the pore, releasing cytochrome c and triggering apoptosis
• C. Low pH activates lysosomal enzymes that degrade damaged proteins; pH normalization halts this protective autophagy
• D. Low pH reduces calcium entry through voltage-gated channels; pH normalization reverses this block

Answer: (B)

The mPTP is a large pore in the inner mitochondrial membrane that, when open, collapses the mitochondrial membrane potential and releases pro-apoptotic factors like cytochrome c. During ischemia, the accumulation of protons (falling pH) holds the mPTP closed — a paradoxical protection against cell death. When reperfusion restores oxygen and pH normalizes, this inhibition is lost: the mPTP opens in a cell that is already calcium-loaded and oxidatively stressed, triggering apoptosis in cells that had survived the ischemic phase. This is why the timing and conditions of reperfusion matter, not just the fact of reperfusion.

Question 3

Longer ischemia duration generally results in greater total tissue damage than shorter ischemia with reperfusion.

• T. True
• F. False

Answer: False

This is a key misconception. Brief ischemia followed by sudden reperfusion can cause disproportionately severe injury because reperfusion injury is substantial when cells are still viable enough to undergo the biochemical cascade (ROS burst, mPTP opening, inflammatory activation). In prolonged ischemia, cells may already be committed to necrosis before reperfusion occurs, so the reperfusion component is relatively less significant. The relationship between ischemia duration and total injury is nonlinear — there is an important period of 'reversible' ischemic injury where reperfusion causes maximum additional harm.

Question 4

Ischemic preconditioning — brief, repetitive ischemic episodes before a sustained ischemic insult — reduces total tissue injury by upregulating cellular protective mechanisms such as heat shock proteins, antioxidant enzymes, and survival kinases.

• T. True
• F. False

Answer: True

Ischemic preconditioning is a real and well-characterized protective phenomenon despite its apparent paradox. Brief, sublethal ischemic episodes activate intracellular signaling cascades that upregulate protective responses: heat shock proteins stabilize proteins under stress, antioxidant enzymes (superoxide dismutase, catalase) increase capacity to neutralize the ROS burst during reperfusion, and survival kinases (RISK pathway: PI3K/Akt and ERK) phosphorylate targets that inhibit the mPTP. The cell, having been warned by small insults, is better prepared for the larger one. This finding has driven research into pharmacological mimetics for use before planned ischemic events like cardiac surgery.

Question 5

Explain why restoring blood flow to ischemic tissue paradoxically causes additional cellular damage beyond what ischemia alone would have produced.

Model answer: Reperfusion delivers oxygen to cells that are already in crisis — ATP-depleted, calcium-loaded, and with partially depolarized mitochondria. The electron transport chain, restarted with oxygen but running chaotically, generates a massive reactive oxygen species burst faster than cellular antioxidants can neutralize. Simultaneously, pH normalization (acidosis was protective by inhibiting the mPTP) causes the mitochondrial permeability transition pore to open, collapsing mitochondrial membrane potential and releasing cytochrome c, triggering apoptosis in cells that survived ischemia. Reperfusion also activates resident macrophages and recruits neutrophils, which amplify oxidant injury via their own oxidative burst.

The paradox of reperfusion injury reveals that oxygen, normally essential for life, is harmful when delivered to cells whose protective machinery has been compromised by ischemia. The same metabolic machinery that generates energy under normal conditions generates toxic oxidants under the disordered conditions of reperfusion. Understanding this has led to therapeutic strategies targeting the ROS burst, the mPTP, and the inflammatory cascade — potentially administered just before reperfusion to limit this 'second hit.'